C
Carole Auger
Researcher at French Institute of Health and Medical Research
Publications - 10
Citations - 917
Carole Auger is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Pituitary tumors & Neurite. The author has an hindex of 9, co-authored 10 publications receiving 782 citations. Previous affiliations of Carole Auger include Claude Bernard University Lyon 1 & Centre national de la recherche scientifique.
Papers
More filters
Journal ArticleDOI
A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case–control study of 410 patients with 8 years post-operative follow-up
Jacqueline Trouillas,Jacqueline Trouillas,Pascal Roy,Nathalie Sturm,Emmanuelle Dantony,Christine Cortet-Rudelli,Gabriel Viennet,Jean-François Bonneville,Richard Assaker,Carole Auger,Carole Auger,Thierry Brue,Aurélie Cornelius,Henry Dufour,Emmanuel Jouanneau,Patrick François,Françoise Galland,François Mougel,François Chapuis,Laurent Villeneuve,Claude-Alain Maurage,Dominique Figarella-Branger,Gérald Raverot +22 more
TL;DR: A new, easy to use clinicopathological classification of pituitary endocrine tumours has demonstrated its prognostic worth by strongly predicting the probability of post-operative complete remission or tumour progression and so could help clinicians choose the best post-operation therapy.
Journal ArticleDOI
A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors
Anne Wierinckx,Carole Auger,Pauline Devauchelle,Arlette Reynaud,Pascale Chevallier,Michel Jan,Gilles Perrin,Michelle Fèvre-Montange,Catherine Rey,Dominique Figarella-Branger,Gérald Raverot,Marie-Françoise Belin,Joël Lachuer,Jacqueline Trouillas +13 more
TL;DR: The similar gene profiles found between non-invasive human and benign rat tumors, as well as between aggressive-in invasive human and malignant rat tumors provide new insights into malignancy in human pituitary tumors.
Journal ArticleDOI
Prognostic factors in prolactin pituitary tumors: clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-up.
Gérald Raverot,Anne Wierinckx,Emmanuelle Dantony,Carole Auger,Guillaume Chapas,Laurent Villeneuve,Thierry Brue,Dominique Figarella-Branger,Pascal Roy,Emmanuel Jouanneau,Michel Jan,Joël Lachuer,Jacqueline Trouillas +12 more
TL;DR: This multiparameter investigation aimed to identify markers for recurrence and progression in prolactin tumors by retrospectively studying clinical data, tumor characteristics, clinical outcome, and the expression of nine genes by quantitative RT-PCR.
Journal ArticleDOI
Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing's disease
Gérald Raverot,Anne Wierinckx,Emmanuel Jouanneau,Carole Auger,Françoise Borson-Chazot,Joël Lachuer,Michel Pugeat,Jacqueline Trouillas +7 more
TL;DR: Despite the absence of clinical hypercortisolism in patients with SCA, elevated plasma ACTH levels that were similar to those associated with mCA were observed and SCA and MCA show hormonal and molecular similarities differentiating them from mCA.
Journal ArticleDOI
CRMP5 Interacts with Tubulin to Inhibit Neurite Outgrowth, Thereby Modulating the Function of CRMP2
Sébastien Brot,Véronique Rogemond,Valérie Perrot,Naura Chounlamountri,Carole Auger,Jérôme Honnorat,Mahnaz Moradi-Améli +6 more
TL;DR: It is found that, in contrast to CRMP2, CRMP5 inhibits tubulin polymerization and neurite outgrowth and, through a tubulin-based mechanism, modulatesCRMP2 regulation of neuriteOutgrowth and neuronal polarity during brain development.